These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 25002294)
1. Elevation of soluble intercellular adhesion molecule-1 levels, but not angiopoietin 2, in the plasma of human immunodeficiency virus-infected African women with clinical Kaposi sarcoma. Graham SM; Rajwans N; Richardson BA; Jaoko W; McClelland RS; Overbaugh J; Liles WC Am J Trop Med Hyg; 2014 Oct; 91(4):705-8. PubMed ID: 25002294 [TBL] [Abstract][Full Text] [Related]
3. Detection of Kaposi's sarcoma-associated herpesvirus in peripheral blood cells in human immunodeficiency virus infection: association with Kaposi's sarcoma, CD4 cell count, and HIV RNA levels. Min J; Katzenstein DA AIDS Res Hum Retroviruses; 1999 Jan; 15(1):51-5. PubMed ID: 10024052 [TBL] [Abstract][Full Text] [Related]
4. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK. Letang E; Lewis JJ; Bower M; Mosam A; Borok M; Campbell TB; Naniche D; Newsom-Davis T; Shaik F; Fiorillo S; Miro JM; Schellenberg D; Easterbrook PJ AIDS; 2013 Jun; 27(10):1603-13. PubMed ID: 23462220 [TBL] [Abstract][Full Text] [Related]
5. A prospective study of endothelial activation biomarkers, including plasma angiopoietin-1 and angiopoietin-2, in Kenyan women initiating antiretroviral therapy. Graham SM; Rajwans N; Tapia KA; Jaoko W; Estambale BB; McClelland RS; Overbaugh J; Liles WC BMC Infect Dis; 2013 Jun; 13():263. PubMed ID: 23734875 [TBL] [Abstract][Full Text] [Related]
6. The clinical application of plasma Kaposi sarcoma herpesvirus viral load as a tumour biomarker: results from 704 patients. Haq IU; Dalla Pria A; Papanastasopoulos P; Stegmann K; Bradshaw D; Nelson M; Bower M HIV Med; 2016 Jan; 17(1):56-61. PubMed ID: 26111246 [TBL] [Abstract][Full Text] [Related]
7. Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era. Bohlius J; Valeri F; Maskew M; Prozesky H; Garone D; Sengayi M; Fox MP; Davies MA; Egger M Int J Cancer; 2014 Dec; 135(11):2644-52. PubMed ID: 24729433 [TBL] [Abstract][Full Text] [Related]
9. Association Between Immunoglobulin E Levels and Kaposi Sarcoma in African Adults With Human Immunodeficiency Virus Infection. Byakwaga H; Barbachano-Guerrero A; Wang D; McAllister S; Naphri K; Laker-Oketta M; Muzoora C; Hunt PW; Martin J; King CA J Infect Dis; 2021 Jan; 223(1):101-108. PubMed ID: 32561934 [TBL] [Abstract][Full Text] [Related]
10. Risk factors for Kaposi's sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virus. Cannon MJ; Dollard SC; Black JB; Edlin BR; Hannah C; Hogan SE; Patel MM; Jaffe HW; Offermann MK; Spira TJ; Pellett PE; Gunthel CJ AIDS; 2003 Jan; 17(2):215-22. PubMed ID: 12545082 [TBL] [Abstract][Full Text] [Related]
11. Similar Immunological Profiles Between African Endemic and Human Immunodeficiency Virus Type 1-Associated Epidemic Kaposi Sarcoma (KS) Patients Reveal the Primary Role of KS-Associated Herpesvirus in KS Pathogenesis. Lidenge SJ; Tso FY; Ngalamika O; Ngowi JR; Mortazavi Y; Kwon EH; Shea DM; Minhas V; Mwaiselage J; Wood C; West JT J Infect Dis; 2019 Apr; 219(8):1318-1328. PubMed ID: 30452681 [TBL] [Abstract][Full Text] [Related]
12. Serum levels of intercellular adhesion molecule 1 in patients with HIV-related Kaposi's sarcoma. De Paoli P; Caffau C; D'Andrea M; Tavio M; Tirelli U; Santini G J Acquir Immune Defic Syndr (1988); 1994 Jul; 7(7):695-9. PubMed ID: 7911526 [TBL] [Abstract][Full Text] [Related]
13. Effect of human immunodeficiency virus-1 protease inhibitors on the clearance of human herpesvirus 8 from blood of human immunodeficiency virus-1-infected patients. Leao JC; Kumar N; McLean KA; Porter SR; Scully CM; Swan AV; Teo CG J Med Virol; 2000 Dec; 62(4):416-20. PubMed ID: 11074468 [TBL] [Abstract][Full Text] [Related]
17. Treatment response and mortality among patients starting antiretroviral therapy with and without Kaposi sarcoma: a cohort study. Maskew M; Fox MP; van Cutsem G; Chu K; Macphail P; Boulle A; Egger M; Africa FI PLoS One; 2013; 8(6):e64392. PubMed ID: 23755122 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of plasma human herpesvirus 8 DNA as a marker of clinical outcomes during antiretroviral therapy for AIDS-related Kaposi sarcoma in Zimbabwe. Borok M; Fiorillo S; Gudza I; Putnam B; Ndemera B; White IE; Gwanzura L; Schooley RT; Campbell TB Clin Infect Dis; 2010 Aug; 51(3):342-9. PubMed ID: 20572760 [TBL] [Abstract][Full Text] [Related]
19. Reduced levels of neutralizing antibodies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma. Kimball LE; Casper C; Koelle DM; Morrow R; Corey L; Vieira J J Infect Dis; 2004 Jun; 189(11):2016-22. PubMed ID: 15143468 [TBL] [Abstract][Full Text] [Related]
20. Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome. Cattelan AM; Calabrò ML; Gasperini P; Aversa SM; Zanchetta M; Meneghetti F; De Rossi A; Chieco-Bianchi L J Natl Cancer Inst Monogr; 2001; (28):44-9. PubMed ID: 11158206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]